Aptamer-Based Strategies to Boost Immunotherapy in TNBC

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with poor outcomes and limited therapeutic options. It is characterized by a more pronounced immunogenicity compared with other breast cancer subtypes, suggesting immunotherapy is a viable strategy. Aptamers...

Descripción completa

Detalles Bibliográficos
Autores principales: Agnello, Lisa, d’Argenio, Annachiara, Nilo, Roberto, Fedele, Monica, Camorani, Simona, Cerchia, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093095/
https://www.ncbi.nlm.nih.gov/pubmed/37046670
http://dx.doi.org/10.3390/cancers15072010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093095/
https://www.ncbi.nlm.nih.gov/pubmed/37046670
http://dx.doi.org/10.3390/cancers15072010

Ejemplares similares